Phase I Single Ascending Dose and Multiple Ascending Dose Study of 2R,6R-Hydroxynorketamine

Clinical Trial Grant

Duke Scholars

Co Investigator David Brett MacLeod Anesthesiology, Regional

Co Investigator Shruti Mukund Raja Neurology, Neuromuscular Disease

Medical Monitor Daniel Todd Laskowitz Neurology, Neurocritical Care

Principal Investigator Jeffrey Guptill Neurology, Neuromuscular Disease

Co Investigator Aatif Mairaj Husain Neurology, Epilepsy and Sleep

Administered By

School of Medicine

Awarded By

National Institutes of Health

Start Date

September 15, 2018

End Date

May 31, 2024

Administered By

School of Medicine

Awarded By

National Institutes of Health

Start Date

September 15, 2018

End Date

May 31, 2024